Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer ; day:17 ; month:9 ; year:2024 ; pages:1-8
Endocrine ; (17.9.2024), 1-8
- Creator
-
Acitelli, E.
Verrienti, A.
Sponziello, M.
Pecce, V.
Minicocci, I.
Macera, M.
Barp, S.
Lucia, P.
Grani, G.
Durante, C.
Maranghi, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12020-024-04003-y
- URN
-
urn:nbn:de:101:1-2411302106343.974689158191
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Acitelli, E.
- Verrienti, A.
- Sponziello, M.
- Pecce, V.
- Minicocci, I.
- Macera, M.
- Barp, S.
- Lucia, P.
- Grani, G.
- Durante, C.
- Maranghi, M.
- SpringerLink (Online service)
Other Objects (12)
High Cholesterol, Triglycerides, and Body-Mass Index in Suicide Attempters
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice
Simultaneous Colorimetric Determination of Cholesterol and Triglycerides in Serum with a Dual-Channel AutoAnalyzer
High Cholesterol, Triglycerides, and Body-Mass Index in Suicide Attempters
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice
Simultaneous Colorimetric Determination of Cholesterol and Triglycerides in Serum with a Dual-Channel AutoAnalyzer
High Cholesterol, Triglycerides, and Body-Mass Index in Suicide Attempters
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice